Literature DB >> 19455602

The association between chorionic villus sampling and preeclampsia.

William A Grobman1, Melissa Auger, Lee P Shulman, Sherman Elias.   

Abstract

OBJECTIVE: To determine whether an association exists between prenatal diagnostic procedures and preeclampsia.
METHODS: All women who underwent invasive prenatal diagnosis and were not at high risk for preeclampsia were identified during a 15-month period and matched by age with women who had not had invasive prenatal diagnosis. The association between prenatal diagnosis [amniocentesis and chorionic villus sampling (CVS)] and the development of preeclampsia was assessed in univariable and multivariable analyses.
RESULTS: Six-hundred and fifty-three women who underwent prenatal diagnosis (501 by amniocentesis and 152 by CVS) were matched by age with 653 women who did not undergo the test. In multivariable analysis, the factors that remained significantly associated with preeclampsia were (1) maternal age less than 25 years (OR 7.4, 95% CI 23.3-23.6); (2) nulliparity (OR 2.7, 95% CI 1.1-6.9); and (3) having had a CVS as a nulliparous woman (OR 4.2, 95% CI 1.4-12.6).
CONCLUSION: These data suggest that CVS is associated with the subsequent development of preeclampsia in nulliparous women; this relationship should be confirmed in further studies.

Entities:  

Mesh:

Year:  2009        PMID: 19455602     DOI: 10.1002/pd.2296

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  Effect of chorionic villus sampling on the occurrence of preeclampsia and gestational hypertension: An updated systematic review and meta-analysis.

Authors:  Ahmet Başaran; Mustafa Başaran; Betül Topatan; James N Martin
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-01-12

2.  Does Chorionic Villus Sampling Increase the Risk of Preeclampsia or Gestational Hypertension?

Authors:  Mahboobeh Shirazi; Maryam Rabiei; Fatemeh Rahimi; Shirin Niroomanesh; Fateme Golshahi; Mitra Eftekhar Yazdi
Journal:  Int J Prev Med       Date:  2019-02-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.